Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells

Experimental Cell Research

Volumn 316, Issue 16, 2010, Pages 2683-2691

  Kucharzewska, Paulina ^a   Welch, Johanna E ^a   Svensson, Katrin J ^a   Belting, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Cancer; Cell migration; Ornithine decarboxylase; Polyamines

Indexed keywords

ACTIN; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEIN CDC42; RAC1 PROTEIN; EFLORNITHINE; ENZYME INHIBITOR; ORNITHINE DECARBOXYLASE INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; MICROCIRCULATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WOUND HEALING;

ACTINS; ANIMALS; BLOTTING, WESTERN; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETON; EFLORNITHINE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITORS; POLYAMINES; RAC1 GTP-BINDING PROTEIN; UMBILICAL VEINS; WOUND HEALING;

EID: 77955847340     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.05.033     Document Type: Article

References (46)

1. Thomas T., Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 2001, 58:244-258.
2. Gerner E.W., Jr Meyskens F.L. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 2004, 4:781-792.
3. Pegg A.E. Regulation of ornithine decarboxylase. J. Biol. Chem. 2006, 281:14529-14532.
4. Casero R.A., Marton L.J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov. 2007, 6:373-390.
5. Casero R.A., Pegg A.E. Polyamine catabolism and disease. Biochem. J. 2009, 421:323-338.
6. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 2010, 42:39-51.
7. Russell D., Snyder S.H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl. Acad. Sci. USA 1968, 60:1420-1427.
8. Sistonen L., Hölttä E., Mäkelä T.P., Keski-Oja J., Alitalo K. The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J. 1989, 8:815-822.
9. Hölttä E., Auvinen M., Andersson L.C. Polyamines are essential for cell transformation by pp 60v-src: delineation of molecular events relevant for the transformed phenotype. J. Cell Biol. 1993, 122:903-914.
10. Yuspa S.H., Lichti U., Ben T., Patterson E., Hennings H., Slaga T.J., Colburn N., Kelsey W. Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature 1976, 262:402-404.
11. Gilmour S.K., Avdalovic N., Madara T., O'Brien T.G. Induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol 13-acetate in hamster fibroblasts. Relationship between levels of enzyme activity, immunoreactive protein, and RNA during the induction process. J. Biol. Chem. 1985, 260:16439-16444.
12. Auvinen M., Paasinen A., Andersson L.C., Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992, 360:355-358.
13. Moshier J.A., Dosescu J., Skunca M., Luk G.D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res. 1993, 53:2618-2622.
14. Kubota S., Kiyosawa H., Nomura Y., Yamada T., Seyama Y. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. J. Natl Cancer Inst. 1997, 89:567-571.
15. Shantz L.M., Pegg A.E. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res. 1994, 54:2313-2316.
16. Clifford A., Morgan D., Yuspa S.H., Soler A.P., Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res. 1995, 55:1680-1686.
17. Megosh L., Gilmour S.K., Rosson D., Soler A.P., Blessing M., Sawicki J.A., O'Brien T.G. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 1995, 55:4205-4209.
18. Metcalf B.W., Bey P., Danzin C., Jung M.J., Casara P., Vevert J.P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 1978, 100:2551-2553.
19. Kubota S., Ohsawa N., Takaku F. Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo. Int. J. Cancer 1987, 39:244-247.
20. Sunkara P.S., Rosenberger A.L. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Res. 1987, 47:933-935.
21. Fong L.Y., Feith D.J., Pegg A.E. Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res. 2003, 63:3945-3954.
22. Keren-Paz A., Bercovich Z., Porat Z., Erez O., Brener O., Kahana C. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Oncogene 2006, 25:5163-5172.
23. Svensson K.J., Welch J.E., Kucharzewska P., Bengtson P., Bjurberg M., Påhlman S., Ten Dam G.B., Persson L., Belting M. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase. Cancer Res. 2008, 68:9291-9301.
24. Folkman J. Tumor angiogenesis: a possible control point in tumor growth. Ann. Intern. Med. 1975, 82:96-100.
25. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
26. Takigawa M., Nishida Y., Suzuki F., Kishi J., Yamashita K., Hayakawa T. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem. Biophys. Res. Commun. 1990, 171:1264-1271.
27. Lima e Silva R., Saishin Y., Saishin Y., Akiyama H., Kachi S., Aslam S., Rogers B., Deering T., Gong Y.Y., Hackett S.F., Lai H., Frydman B.J., Valasinas A., Marton L.J., Campochiaro P.A. Suppression and regression of choroidal neovascularization by polyamine analogues. Invest. Ophthalmol. Vis. Sci. 2005, 46:3323-3330.
28. Auvinen M., Laine A., Paasinen-Sohns A., Kangas A., Kangas L., Saksela O., Andersson L.C., Hölttä E. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res. 1997, 57:3016-3025.
29. Lan L., Trempus C., Gilmour S.K. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Cancer Res. 2000, 60:5696-5703.
30. Takigawa M., Enomoto M., Nishida Y., Pan H.O., Kinoshita A., Suzuki F. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res. 1990, 50:4131-4138.
31. Mani K., Sandgren S., Lilja J., Svensson K., Persson L., Belting M. HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumor cells. Mol. Cancer Ther. 2007, 6:782-788.
32. Kucharzewska P., Welch J.E., Svensson K.J., Birgersson J., Belting M. Establishment of heparan sulphate deficient primary endothelial cells from EXT-1flox/flox mouse lungs and sprouting aortas. In Vitro Cell Dev. Biol. Anim. Apr 10 2010, Epub ahead of print.
33. McCormack S.A., Wang J.Y., Johnson L.R. Polyamine deficiency causes reorganization of F-actin and tropomyosin in IEC-6 cells. Am. J. Physiol. 1994, 267:C715-C722.
34. Kucharzewska P., Welch J.E., Svensson K.J., Belting M. The polyamines regulate endothelial cell survival during hypoxic stress through PI3K/AKT and MCL-1. Biochem. Biophys. Res. Commun. 2009, 380:413-418.
35. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
36. Kobayashi T., Hino S., Oue N., Asahara T., Zollo M., Yasui W., Kikuchi A. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Mol. Cell. Biol. 2006, 26:898-911.
37. Nobes C.D., Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 1999, 144:1235-1244.
38. Ilić D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995, 377:539-544.
39. Cary L.A., Chang J.F., Guan J.L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 1996, 109:1787-1794.
40. Ray R.M., Viar M.J., McCormack S.A., Johnson L.R. Focal adhesion kinase signaling is decreased in polyamine-depleted IEC-6 cells. Am. J. Physiol. Cell Physiol. 2001, 281:C475-C485.
41. Cain R.J., Ridley A.J. Phosphoinositide 3-kinases in cell migration. Biol. Cell 2009, 101:13-29.
42. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
43. Vaidya R.J., Ray R.M., Johnson L.R. Akt-mediated GSK-3beta inhibition prevents migration of polyamine-depleted intestinal epithelial cells via Rac1. Cell. Mol. Life Sci. 2006, 63:2871-2879.
44. Koivisto L., Alavian K., Hakkinen L., Pelech S., McCulloch C.A., Larjava H. Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes. J. Cell Sci. 2003, 116:3749-3760.
45. Aspenström P., Fransson A., Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 2004, 377:327-337.
46. Carlier M.F., Ducruix A., Pantaloni D. Signalling to actin: the Cdc42-N-WASP-Arp2/3 connection. Chem. Biol. 1999, 6:R235-R240.